「the first」の検索結果
22件：11～15件目を表示
-
Management Policy | About Senju | SENJU Pharmaceutical
valuable for society, we are committed to pursuing happiness for all people associated with Senju rather than just becoming a “big company” that pursues only greater growth and increased sales. Action...
http://www.senju.co.jp/english/about/philosophy.html -
Management Policy | About Senju | SENJU Pharmaceutical
valuable for society, we are committed to pursuing happiness for all people associated with Senju rather than just becoming a “big company” that pursues only greater growth and increased sales. Action...
https://www.senju.co.jp/english/about/philosophy.html -
g approval in Japan as of December 22, 2025. Avarept® Ophthalmic suspension 0.3% represents a novel therapy for DED with Transient Receptor Potential cation channel subfamily V member 1 (TRPV1)*1 anta...
https://www.senju.co.jp/system/files/content_news/2025-12/ENG_20251222.pdf -
g approval in Japan as of December 22, 2025. Avarept® Ophthalmic suspension 0.3% represents a novel therapy for DED with Transient Receptor Potential cation channel subfamily V member 1 (TRPV1)*1 anta...
https://www.senju.co.jp/system/files/content_news/2025-12/ENG_20251222_0.pdf -
Product Development Policy | Research & Development | SENJU Pharmaceutica
Corporate Strategy DivisionProduct Planning DepartmentDirectorYasunobu Maenaka With the management philosophy of “Good Company” and a company that shapes “Beyond eyesight,” we have developed products ...
http://www.senju.co.jp/english/rd/policy/